{"disease":{"id":"fungal-keratitis","name":"Fungal keratitis","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":2,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"natacyn","indication_name":"Fungal keratitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"NATACYN®","company_name":"IVIEW Therapeutics Inc.","drug_phase":"marketed","molecular_target":"","drug_class":"Polyene Antimicrobial","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"natamycin","indication_name":"Fungal keratitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Natacyn","generic_name":"NATAMYCIN","company_name":"Harrow Health","drug_phase":"marketed","molecular_target":"","drug_class":"Polyene Antimicrobial [EPC]","quality_score":10,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05110001","title":"Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":330,"lead_sponsor_name":"University of California, San Francisco","has_results":true},{"nct_id":"NCT06658002","title":"Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT05655689","title":"The Antibiogram and Outcomes of Antimicrobial Regimens in Microbial Keratitis: A Prospective Cohort Study","phase":"","overall_status":"COMPLETED","enrollment_count":123,"lead_sponsor_name":"Alexandria University","has_results":false},{"nct_id":"NCT06463678","title":"Trial to Evaluate the Efficacy And Safety of IVIEW-1201 In the Treatment of Fungal Keratitis","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"IVIEW Therapeutics Inc.","has_results":false},{"nct_id":"NCT07557966","title":"Intrastromal Injection of Fluconazole in Treatment of Fungal Keratitis","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Tanta University","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}